 Effects antiretroviral dideoxynucleosides polymorphonuclear leukocyte function Dideoxynucleosides zidovudine AZT dideoxycytidine ddC ddI new agents management human immunodeficiency virus type infections light recent data defects polymorphonuclear leukocyte PMN activity patients many chemotherapeutic agents PMN function effects function PMNs healthy individuals vitro AZT microM ddC microM ddI microM effect viability chemotaxis N-fromylmethionyl leucyl phenylalanine phagocytosis Candida albicans Staphylococcus superoxide production stimulation N-formylmethionyl leucyl phenylalanine Killing albicans AZT microM ddc microM controls microM ddI microM controls aureus unchanged AZT ddC ddI microM microM controls addition defective bactericidal capacity PMNs patients ddI Potential enhancement dideoxynucleosides certain PMN functions patients study